Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on rotavirus vaccines.

Joseph S Bresee1, Umesh D Parashar, Marc-Alain Widdowson

  • 1Respiratory and Enteric Virus Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. jbresee@cdc.gov

The Pediatric Infectious Disease Journal
|November 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rotavirus mucosal immunology: insights and research priorities from an international convening in Liverpool, March 2024.

NPJ vaccines·2026
Same author

COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024.

BMJ global health·2026
Same author

Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investment.

Vaccine·2025
Same author

Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap.

Vaccine·2025
Same author

Lessons learned from the COVID-19 pandemic: opportunities and challenges to leverage investments in HIV, tuberculosis and malaria for pandemic preparedness and response.

BMJ global health·2025
Same author

Severity Scale of Influenza and Acute Respiratory Illness Hospitalizations to Support Viral Genomic Surveillance: A Global Influenza Hospital Surveillance Network Pilot Study.

Influenza and other respiratory viruses·2025
Same journal

A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings.

The Pediatric infectious disease journal·2026
Same journal

Model-based Differentiation Between Kawasaki Disease and MIS-C: The Importance of the Mitral Valve.

The Pediatric infectious disease journal·2026
Same journal

Pulmonary Embolism in Invasive Salmonella Infection: A Rare Cause of Acute Respiratory Failure in an Adolescent.

The Pediatric infectious disease journal·2026
Same journal

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same journal

Determinants of Severity in Pediatric Viral Lower Respiratory Tract Diseases From Emergency Department Presentation to Hospital Course.

The Pediatric infectious disease journal·2026
Same journal

Oropharyngeal Colonization by Kingella kingae and Septic Arthritis in Children 6-48 Months of Age: A Portuguese Multicenter Case-control Study.

The Pediatric infectious disease journal·2026
See all related articles

Rotavirus, a common cause of gastroenteritis, has seen vaccine development since the 1980s. This review covers rotavirus epidemiology, vaccine history, and strategies for global vaccination program implementation.

Area of Science:

  • Virology
  • Epidemiology
  • Vaccinology

Background:

  • Rotavirus was identified in 1973 as a significant cause of severe diarrheal disease in infants and young children worldwide.
  • The development of rotavirus vaccines began with clinical trials reported in 1983, marking a crucial step in controlling this pathogen.

Purpose of the Study:

  • To provide a comprehensive review of the current epidemiology of rotavirus infections globally.
  • To assess the efficacy and safety of existing and novel rotavirus vaccines.
  • To propose strategies for the successful implementation of rotavirus vaccination programs in diverse healthcare settings.

Main Methods:

  • Literature review of epidemiological data on rotavirus prevalence and disease burden.
  • Analysis of published clinical trial data for rotavirus vaccines.

Related Experiment Videos

  • Synthesis of information on vaccine delivery and program implementation challenges.

    • Main Results:

    • Rotavirus remains a leading cause of severe diarrhea in children under five, particularly in low-income countries.
    • Multiple rotavirus vaccines have demonstrated significant efficacy in reducing severe rotavirus gastroenteritis.
    • Implementation challenges include vaccine cost, cold chain logistics, and public health infrastructure.

    Conclusions:

    • Rotavirus vaccination is a critical public health intervention for reducing childhood morbidity and mortality.
    • Tailored strategies are needed for effective vaccine program implementation in both developed and developing nations.
    • Continued surveillance and vaccine research are essential for long-term rotavirus control.